CTMP, a predictive biomarker for trastuzumab resistance in HER2-enriched breast cancer patient.
Oncotarget
; 8(18): 29699-29710, 2017 May 02.
Article
in En
| MEDLINE
| ID: mdl-27447863
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Thiolester Hydrolases
/
Breast Neoplasms
/
Receptor, ErbB-2
/
Drug Resistance, Neoplasm
/
Adaptor Proteins, Signal Transducing
/
Trastuzumab
/
Antineoplastic Agents, Immunological
/
Membrane Proteins
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Oncotarget
Year:
2017
Document type:
Article
Affiliation country:
Taiwán
Country of publication:
Estados Unidos